Destaques
Estudo afirma que o uso de melatonina para dormir está em alta, apesar dos potenciais prejuízos à saúde.
4 Fev, 2022 | 15:58hUsing melatonin for sleep is on the rise, study says, despite potential health harms – CNN
Estudo original: Trends in Use of Melatonin Supplements Among US Adults, 1999-2018 – JAMA (gratuito por tempo limitado)
Perspectiva | Evitar betabloqueadores em pacientes em uso de estimulantes não é apoiado por boas evidências.
4 Fev, 2022 | 15:57hComissão Lancet | Especialistas alertam para o aumento da supermedicalização da morte e fazem um chamado para repensar, radicalmente, o modo como a sociedade cuida das pessoas em fase final de vida.
4 Fev, 2022 | 15:16hComunicado de imprensa: THE LANCET: Experts warn of the increasing overmedicalization of death, call for radical rethink of how society cares for dying people
Página principal: Lancet Commission on the Value of Death (necessário cadastro gratuito para todos os artigos)
Report of the Lancet Commission on the Value of Death: bringing death back into life
The precariousness of balancing life and death
Ros Taylor: seeing palliative care as relational
Conteúdo relacionado: What would it take to die well? A systematic review of systematic reviews on the conditions for a good death – The Lancet Health Longevity
Comentário no Twitter (fio – clique para saber mais)
Increasing overmedicalisation at the end of life is denying people & their families a good death.
Towards a compassionate community model: The Lancet #ValueofDeath Commission calls for a radical rethink of care for the dying & attitudes to death. https://t.co/DpJiu1tOcV pic.twitter.com/FU9MgCO1J6
— The Lancet (@TheLancet) January 31, 2022
Atualização do consenso de especialistas sobre a classificação SCAI SHOCK do choque cardiogênico.
4 Fev, 2022 | 15:14hComunicado de imprensa: SCAI releases updated expert consensus to SCAI SHOCK classification – Society for Cardiovascular Angiography and Interventions
Comentários:
SCAI SHOCK: Update Refines Cardiogenic Shock Classification – TCTMD
SCAI Releases Updated Expert Consensus to SCAI SHOCK Classification – American College of Cardiology
Comentários no Twitter
.@SCAI SHOCK stage is an indication of shock severity & comprises one component of mortality risk prediction in pts w/ CS, along w/ etiology/phenotype & other risk modifiers; a 3-axis model of risk stratification in CS has been proposed. Learn more: https://t.co/tnh2JFhHzN #JACC pic.twitter.com/yK2ye9wcd0
— JACC Journals (@JACCJournals) January 31, 2022
SCAI SHOCK Stage Classification Expert Consensus Update released today in the inaugural issue of @MyJSCAI and also in @JACCJournals. Thank you to endorsing societies @ACCinTouch @american_heart @ACEPNow @escardio @ACVCPresident @ISHLT @SCCM @STS_CTsurgery https://t.co/GHrYn5I5WO pic.twitter.com/Y0mKC0zONu
— SCAI Now (@SCAI) January 31, 2022
Recomendações da OMS para redução do risco de declínio cognitivo e demência.
4 Fev, 2022 | 15:12hReducing the Risk of Cognitive Decline and Dementia: WHO Recommendations – Frontiers in Neurology
Conteúdos relacionados:
New WHO toolkit promotes inclusion of people with dementia in society.
Dementia: number of people affected to triple in next 30 years – World Health Organization
Estudo observacional | Envolvimento farmacêutico no cuidado de pacientes críticos pode reduzir a utilização de recursos, os eventos adversos medicamentosos e os custos médicos.
4 Fev, 2022 | 15:11h
Comentário do autor no Twitter (fio – clique para saber mais)
PHARM-CRIT Study
👩🔬 215 ICU PharmDs at 85 centers
💊55,926 accepted interventions on 27,681 patients over 3,148 shifts
💵$23,404,089 cost avoidance; monetary benefit-to-cost ratio for ICU pharmacists $3.3:1 – $9.6:1@SCCM_CPP @SCCM #TwitteRx #PharmICU https://t.co/Hv4jPwU6eb— Megan Rech, PharmD, MS (@MeganARech) December 16, 2021
Estudo randomizado | Impacto de máquina portátil normotérmica de perfusão sobre os desfechos de transplante hepático.
4 Fev, 2022 | 15:09hComentários:
Normothermic Machine Perfusion Improves Outcomes in Liver Transplant Recipients – Physician’s Weekly
Machine Perfusion Cuts Early Graft Dysfunction in Liver Transplantation – MedPage Today (necessário cadastro gratuito)
Conteúdos relacionados:
RCT: Hypothermic machine perfusion in liver transplantation
Transplantation of Discarded Livers Following Viability Testing with Normothermic Machine Perfusion
Comentários no Twitter
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/PZzvFriJvB pic.twitter.com/2icSfxoLDF
— JAMA Surgery (@JAMASurgery) January 5, 2022
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/TKEsTf8Htu pic.twitter.com/tg2xDGDyOS
— JAMA Surgery (@JAMASurgery) January 5, 2022
[Preprint] Estudo sugere que a subvariante BA.2 do SARS-CoV-2 é ainda mais transmissível do que a variante Ômicron original.
4 Fev, 2022 | 15:08hComentários:
Study suggests BA.2 COVID-19 subvariant more contagious – CIDRAP
‘Stealth Omicron’ spreads more than original strain: study – MedicalXpress
Comentário do autor no Twitter (fio – clique para saber mais)
New Preprint Out!
“Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households”
We investigate the secondary attack rate (SAR) in #Omicron BA.1 vs. BA.2 households in Demark, 20 December 2021 – 18 January 2022.https://t.co/F3XBH2LnW9
1/ pic.twitter.com/MwGPNYkOg8— Frederik Plesner Lyngse (@LyngseF) January 31, 2022
A Ômicron vai acabar com a pandemia? Veja o que dizem os especialistas.
4 Fev, 2022 | 15:06hWill Omicron end the pandemic? Here’s what experts say – Nature
O mundo precisa de uma vacina contra a Ômicron? O que dizem os pesquisadores.
4 Fev, 2022 | 15:05hDoes the world need an Omicron vaccine? What researchers say – Nature